Sign In
Buy RCEL
$4.16
-0.0300 (-0.716%)
At Close: Jun 03, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL
10:00am, Saturday, 13'th Sep 2025
NEW YORK , Sept. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AVITA Medical, Inc. ("Avita" or the "Company") (NASDAQ: RCEL).
RCEL Investors Have Opportunity to Join AVITA Medical, Inc. Fraud Investigation with the Schall Law Firm
03:31pm, Thursday, 11'th Sep 2025
LOS ANGELES--(BUSINESS WIRE)---- $RCEL--RCEL Investors Have Opportunity to Join AVITA Medical, Inc. Fraud Investigation with the Schall Law Firm.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL
02:51pm, Wednesday, 10'th Sep 2025
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of AVITA Medical, Inc. (“Avita” or the “Company”) (NASDAQ: RCEL). Such investors
AVITA Medical, Inc. Investors: Company Investigated by the Portnoy Law Firm
03:47pm, Tuesday, 09'th Sep 2025
Investors can contact the law firm at no cost to learn more about recovering their losses
RCEL Alert: Kirby McInerney LLP Encourages AVITA Medical, Inc. Investors to Inquire about Investigation
12:41pm, Tuesday, 09'th Sep 2025
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of AVITA Medical, Inc. (“AVITA” or the “Company”) (NASDAQ:RCEL) investors concernin
AVITA Medical, Inc. (RCEL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
06:23pm, Monday, 08'th Sep 2025
AVITA Medical, Inc. (NASDAQ:RCEL ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 4:05 PM EDT Company Participants James Corbett - CEO, President & Executive Director Presen
LOS ANGELES, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of AVITA Medical, Inc. (“Avita” o
AVITA Medical, Inc. (RCEL) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
05:00pm, Wednesday, 03'rd Sep 2025
BENSALEM, Pa., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its investigation on behalf of AVITA Medical, Inc. (“Avita” or the “Company”) (NASDAQ: RCEL) investo
LOS ANGELES, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of AVITA Medical, Inc. (“Avita” or the “Company”) (NASDAQ: RCEL) on behalf of inves
AVITA Medical, Inc. Investors: Company Investigated by the Portnoy Law Firm
03:41pm, Thursday, 28'th Aug 2025
Investors can contact the law firm at no cost to learn more about recovering their losses
On August 8, 2025, Avita shares fell 21% to $4.25 after revealing unpaid Recell claims caused a demand drop due to CMS pricing and adjudication delays.
Kirby McInerney LLP Announces Investigation Against AVITA Medical, Inc. on Behalf of Investors
05:52pm, Friday, 22'nd Aug 2025
NEW YORK, Aug. 22, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against AVITA Medical, Inc. (“AVITA” or the “Company”) (NASDAQ: RCEL). The inv
INVESTOR ALERT: Investigation of AVITA Medical, Inc. (RCEL) Announced by Holzer & Holzer, LLC
12:04pm, Friday, 22'nd Aug 2025
ATLANTA, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether AVITA Medical, Inc. (“AVITA” or the “Company”) (NASDAQ: RCEL) complied with federal securities laws. O
AVITA Medical Announces September Investor Conference Participation
04:05pm, Thursday, 21'st Aug 2025
VALENCIA, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced th
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of AVITA Medical, Inc. (“A
